Agios Pharmaceuticals, Inc.
AGIO· Nasdaq
AGIOAgios Pharmaceuticals, Inc.
Source filing unavailable
| Metric | Q1 2014 | Q1 2013 | Q1 2012 |
|---|---|---|---|
| Revenue | $8.41M | $6.27M | $6.27M |
| Net Income | -$12.25M | -$7.23M | -$4.63M |
| EPS Diluted | -$0.39 | -$2.47 | -$1.98 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Agios Pharmaceuticals, Inc. · CIK 1439222 · Engraved from SEC EDGAR
